Monitoring Cord Blood Inventory Reliability By Key Quality Indicators At And After Release


Processes surrounding the implementation of cell therapies require advanced consideration to ensure safety and efficacy. Innovative modalities such as cell therapies are time- and temperature-sensitive, making the packaging of and logistics for materials complex.

As per FACT standards, Cord Blood Banks (CBB) have to verify that they provide a safe and effective product for transplant. Validated processing methods and storage conditions are the first steps towards this goal, but what are the final steps to monitor the quality of the cord blood units (CBU) released for transplant? We present here a retrospective analysis of our Program’s final verification process.

access the Poster!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma

Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises